Efficacy and Safety of Docetaxel Plus Oxaliplatin and Capecitabine in the First Line Treatment of Advanced Gastric Adenocarcinoma

Table 2

Grade 3-4 toxicities of DOX regimen.

Toxicity	𝑛 (%)
Hematological toxicity
Leukopenia	14 (37.8)
Neutropenia	14 (37.8)
Febrile neutropenia	4 (10.8)
Nonhematological toxicity
Gastrointestinal toxicity
Nausea	2 (5.4)
Vomiting	2 (5.4)
Anorexia	3 (8.1)
Diarrhea	1 (2.7)
Neurosensory toxicity	1 (2.7)
Hepatic	1 (2.7)
Other
Fatigue	10 (27.0)
Hand-foot syndrome	3 (8.1)